Epoetin alfa biosimilar (Biocon)

阿法依伯汀生物类似药 (Biocon)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (Biocon)
Drug Alias Name阿法依伯汀生物仿制药 (Biocon)Erypro PrefilErypro safeRecombinant human erythropoietin injection (Biocon)Erypro
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2011/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiocon Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesBiocon Biopharmaceuticals
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A